Skip to content

pn_blog-post_alert-logo_hubspot

PN_email_Headers_Alert-Banner

FDA Approves Centanafadine for ADHD

7/27/26 2:52 PM

The FDA has approved Otsuka Pharmaceutical’s SIMTRIYO (centanafadine) for the treatment of attention...

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Sign up to receive each post directly into your inbox:

cover_July 2026

News From Current Issue

Special Report: Lithium Clinics and High-Risk Populations With Bipolar Disorder
Point/Counterpoint: Is Lithium the Gold Standard for Bipolar Disorder?
The War on SSRIs

Read This Week's Update

PN_email_Headers_Update-Banner

The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.